Back to Search
Start Over
568P First-line (1L) osimertinib + platinum-pemetrexed in EGFR-mutated (EGFRm) advanced NSCLC: Updated FLAURA2 safety run-in (SRI) results.
- Source :
-
Annals of Oncology . 2023 Supplement 4, Vol. 34, pS1692-S1693. 2p. - Publication Year :
- 2023
- Subjects :
- *OSIMERTINIB
*NON-small-cell lung carcinoma
*SAFETY
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 34
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 173758525
- Full Text :
- https://doi.org/10.1016/j.annonc.2023.10.646